Planet Labs Available For Sale Securities Debt Securities Current increased by 75.5% to $410.65M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 294.8%, from $104.03M to $410.65M.
An increase suggests higher liquidity and a conservative cash management strategy, while a decrease may indicate cash deployment for operations or acquisitions.
This represents the portion of a company's investment portfolio consisting of debt securities that are expected to be so...
Common among large-cap pharmaceutical firms maintaining significant cash reserves for R&D and M&A activities.
current_assets_available_for_sale_securities_debt_securi_87ec82| Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $195.63M | $226.16M | $226.87M | $235.42M | $248.98M | $213.35M | $215.04M | $168.22M | $101.10M | $103.26M | $104.03M | $92.62M | $90.45M | $233.98M | $410.65M |
| QoQ Change | — | — | +15.6% | +0.3% | +3.8% | +5.8% | -14.3% | +0.8% | -21.8% | -39.9% | +2.1% | +0.7% | -11.0% | -2.3% | +158.7% | +75.5% |
| YoY Change | — | — | — | — | — | +27.3% | -5.7% | -5.2% | -28.5% | -59.4% | -51.6% | -51.6% | -44.9% | -10.5% | +126.6% | +294.8% |